A detailed history of Legacy Advisory Services, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Legacy Advisory Services, LLC holds 265 shares of LLY stock, worth $270,750. This represents 0.15% of its overall portfolio holdings.

Number of Shares
265
Holding current value
$270,750
% of portfolio
0.15%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Oct 30, 2025

BUY
$625.65 - $812.69 $165,797 - $215,362
265 New
265 $202 Million
Q1 2025

May 19, 2025

BUY
$725.72 - $929.72 $390,437 - $500,189
538 New
538 $444 Million
Q4 2024

Oct 17, 2025

BUY
$727.2 - $932.06 $97,444 - $124,896
134 Added 35.17%
515 $398 Million
Q3 2024

Oct 17, 2025

BUY
$772.14 - $960.02 $294,185 - $365,767
381 New
381 $338 Million
Q2 2024

Oct 17, 2025

BUY
$724.87 - $909.04 $276,175 - $346,344
381 New
381 $338 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $971B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Legacy Advisory Services, LLC Portfolio

Follow Legacy Advisory Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Legacy Advisory Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Legacy Advisory Services, LLC with notifications on news.